BeaconEquity.com announces the publication of ‘Biogen Idec Inc. (Nasdaq: BIIB) Finds Strength with Strong Drug Sales’
Investors can view all of the investment articles for free by visiting:
http://www.beaconequity.com/m - Click on News and Commentary
Biogen Idec Inc. (Nasdaq: BIIB) Finds Strength with Strong Drug Sales
”Disease modifying drugs on the multiple sclerosis (MS) market appear to have a favorable outlook in the industry. Meanwhile, market analysis and forecasts reports seem to suggest a positive outlook ahead of these players. According to World Health Organization (WHO) estimates, more than 2.5 million people globally suffer from MS. The prevalence and onset of this autoimmune condition in children and particularly adults is expected to rise exponentially, with the anticipated global population growth rate to reach 7.6 billion by 2020…
“One company poised to perform well in the market is Biogen Idec Inc. This Cambridge, Massachusetts-based biotechnology company engages in the discovery, development, manufacturing and commercialization of innovative therapies, addressing diseases such as lymphoma, MS and rheumatoid arthritis…
“Today, Biogen Idec's outlook brightened as it posted an 11% rise in second-quarter net income…”
To read the entire article visit http://www.beaconequity.com/m – Click on News and Commentary
Join the fastest growing investor community at:
http://www.stockhideout.com
BeaconEquity.com’s Market News is one of the fastest growing small cap blogs in the investment community. Beacon is the authority on research in the small cap sector, and our analysts strive each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.
We encourage investors to subscribe to our FREE newsletter filled with daily trading ideas by visiting: http://www.beaconequity.com/m
BeaconEquity.com is one of the industry’s largest small cap research providers. Beacon strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Beacon Research, please visit: http://www.beaconequity.com/m
Source: BeaconEquity.com
Beacon Equity Research
Jeff Bishop, (469)-252-3505
press@beaconequity.com
